Amgen In Precision Medicine Deal With Syapse
socalTECH
MAY 3, 2019
Thousand Oaks-based biotechnology giant Amgen has entered into a new collaboration effort, with precision medicine developer Syapse. According to the two companies, they will develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology. The two said the joint effort will identify existing patients within the Syapse Learning Health Network that could be eligible for Amgen-sponsored clinical trials and seek to bring these trials to community health syst
Let's personalize your content